Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Netherlands" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
Facts & Figures
Provision & Funding
Basic Health Insurance
Supplementary Health Insurance
WGP Price Revisions
Price Negotiations and Tendering
Controversy over Hospital Medicines Prices
Joint Purchasing Schemes
Admission to Reimbursement
Barriers to Access
Changes in Reimbursement Prices
Proposed QALY Threshold
5. PRICE BUILD UP
6. COST CONTAINMENT
Other Charges for Prescription Medicines
7. FUTURE DEVELOPMENTS
Medicines Policy Plan
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/bxn3fj/ims
View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006076/en/Business Wire
Last updated on: 05/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.